• Info
  • Insider Trading

Brandon D. Smith - Insider Trading & Ownership

Location
C/O Impel Pharmaceuticals Inc., 201 Elliott Avenue West, Suite 260, Seattle, WA
Signature
/s/ Brandon D. Smith
All Insider Reports
All Insider Reports

Notify me when Brandon D. Smith files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Brandon D. Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IMPL IPI Legacy Liquidation Co Chief Restructuring Officer Dec 18, 2023

There are no insider transactions reported by Brandon D. Smith